UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009243 |
|---|---|
| Receipt number | R000010844 |
| Scientific Title | A randomized phase2 study of bendamustine plus Rituximab for relapsing or refractory follicular lymphoma comparing 90 mg/sqm BR vs. 120 mg/sqm BR. |
| Date of disclosure of the study information | 2012/12/01 |
| Last modified on | 2020/03/25 11:41:52 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/11/01 14:30:29 | ||
| 2 | Update | 2020/03/25 11:41:53 | Recruitment status Date of IRB Last follow-up date |
